PhenX - personal and family history of psoriasis protocol 170501:-:Pt: Patient:-:PhenX - CISMeF
PhenX - personal and family history of psoriasis protocol 170501:-:Pt: Patient:-:PhenXLOINC code
Preferred Label : PhenX - personal and family history of psoriasis protocol 170501:-:Pt: Patient:-:PhenX;
LOINC status : TRIAL;
LOINC long common name : PhenX - personal and family history of psoriasis protocol 170501;
LOINC short name : Pers fam hx psoriasis proto;
LOINC description : The Self Evaluation plus Medication Survey is a self-administered instrument which
was developed from the questionnaires used in the Collaborative Association Study
of Psoriasis (CASP), which is a Genetic Association Information Network (GAIN) genome-wide
association study (GWAS). The Self Evaluation plus Medication Survey collects information
on individuals with psoriasis and controls, and their family history of psoriasis
and other autoimmune diseases. Additionally, for individuals with psoriasis the questionnaire
collects information regarding their symptoms and medication use and its effectiveness.
The PhenX Skin, Bone, Muscle and Joint Working Group (WG) recommends that investigators
provide participants with an informed consent form which allows future contact for
physician validation of their diagnosis and to update information on their health
status. Immediately following the alcohol and tobacco questions, the Self Evaluation
plus Medication Survey asked questions regarding the respondent's weight and height.
These questions have been deleted. The Working Group recommends that this information
be obtained via the PhenX measures titled Weight and Height, respectively. These measures
are located in the PhenX Toolkit, under the Anthropometrics domain.;